IP Library › Assignment 039116/0827
Patent Assignment
Reel/Frame 039116/0827

Assignment of Assignor's Interest

Recorded: 2016-06-22 Pages: 28
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2016-05-06
Assignee
ALBANY MOLECULAR RESEARCH, INC.
26 CORPORATE CIRCLE, ALBANY, NEW YORK, 12203
Covered Properties (33)
Aryl-And Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Aryl-And Heteroaryl-Substituted Tetrahydrobenzazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Aryl- and Heteroaryl-Substituted Tetrahydrobenzo-1,4-Diazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Aryloxy-And Heteroaryloxy-Substituted Tetrahydrobenzazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Processes for Preparing Tetrahydroisoquinolines
Crystalline Forms of (S)-7-([1,2,4]Triazolo[1,5-a]Pyridin-6-Yl)-4-(3,4-Dichlorohphenyl)-1,2,3,4-Tetrahydroisoquinoline and Use Thereof
2,5-Methano-And 2,5-Ethano-Tetrahydrobenzazepine Derivatives and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Processes for Preparing Tetrahydroisoquinolines
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 7,541,357 →
Application: 11/183,066 →
Publication: US 2006/0052378
Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin
Application: 11/183,102 →
Publication: US 2006/0063766
Aryl-And Heteroaryl-Substituted Tetrahydrobenzazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 7,956,050 →
Application: 11/487,884 →
Publication: US 2007/0021408
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 8,227,486 →
Application: 12/252,823 →
Publication: US 2009/0048443
Aryl- and Heteroaryl-Substituted Tetrahydrobenzazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Application: 12/253,170 →
Publication: US 2009/0118260
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 8,236,796 →
Application: 12/417,598 →
Publication: US 2009/0253906
CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF
Patent: 8,815,894 →
Application: 12/777,840 →
Publication: US 2010/0292250
Aryl- and Heteroaryl-Substituted Tetrahydrobenzazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 8,791,101 →
Application: 12/917,066 →
Publication: US 2011/0046114
2,5-Methano- and 2,5-Ethano-Tetrahydrobenzazepine Derivatives and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 9,045,468 →
Application: 13/211,678 →
Publication: US 2012/0046271
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 8,741,901 →
Application: 13/540,446 →
Publication: US 2013/0005965
Tetrahydroisoquinolines and Intermediates Therefor
Application: 13/664,546 →
Publication: US 2013/0060027
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Patent: 9,156,812 →
Application: 13/845,919 →
Publication: US 2014/0275101
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 9,085,531 →
Application: 14/268,753 →
Publication: US 2014/0243524
Aryl- and Heteroaryl-Substituted Tetrahydrobenzazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 9,403,776 →
Application: 14/304,833 →
Publication: US 2014/0296514
CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
Patent: 9,173,879 →
Application: 14/466,009 →
Publication: US 2014/0364441
Tetrahydroisoquinolines and Intermediates Therefor
Application: 14/661,063 →
Publication: US 2015/0191494
Aryl- and Heteroaryl-Substituted Tetrahydroisoquinolines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Patent: 9,499,531 →
Application: 14/737,897 →
Publication: US 2015/0274713
Crystalline Form of 6-[(4S)-2-Methyl-4-(2-Naphthyl)-1,2,3,4-Tetrahydroisoquinolin-7-Yl]Pyridazin-3-Amine
Patent: 9,498,476 →
Application: 14/841,024 →
Publication: US 2015/0366864
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
Application: 60/588,448 →
Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
Application: 60/700,057 →
Aryl- and Heteroaryl-Substituted Tetrahydrobenzo-1,4-Diazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Application: 60/917,189 →
Aryloxy- and Heteroaryloxy-Substituted Tetrahydrobenzazepines and Use Thereof to Block Reuptake of Norepinephrine, Dopamine, and Serotonin
Application: 60/917,200 →
CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROPHENYL)-1,2,3,4- TETRAHYDROISOQUINOLINE AND USE THEREOF
Application: 61/177,486 →
2,5-Methano- and 2,5-Ethano-Tetrahydrobenzazepine Derivatives And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, and Serotonin
Application: 61/374,470 →
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 16, 2014
From: GONZALEZ-BOBES, FRANCISCO; CONLON, DAVID ALAN; LOBBEN, PAUL C.; BURT, JUSTIN LOCKHEART
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 032910/0382 →
Release of Security Interest Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
Security Interest Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
Security Interest Aug 5, 2015
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI SSCI, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 036257/0914 →
Release of Security Interest Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
Reel/Frame 043742/0085 →
Second Lien Security Agreement Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
First Lien Security Agreement Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
Corrective Assignment to Correct the Incorrect Patent No. 7541537 Previously Recorded at Reel: 034045 Frame: 0951. Assignor(S) Hereby Confirms the Security Interest. Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
Release of Security Interest Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.
Reel/Frame 054252/0687 →
Release of Security Interest Nov 16, 2020
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 054382/0326 →
Security Interest Sep 6, 2021
From: CURIA GLOBAL, INC. (FKA ALBANY MOLECULAR RESEARCH, INC.); CURIA MASSACHUSETTS, INC. (FKA AMRI BURLINGTON, INC.); CURIA WISCONSIN, INC. (FKA CEDARBURG PHARMACEUTICALS, INC.); CURIA INDIANA, LLC (FKA AMRI SSCI, LLC)
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 057423/0665 →
Assignment of Assignor's Interest Dec 5, 2023
From: CURIA GLOBAL, INC. (F/K/A ALBANY MOLECULAR RESEARCH, INC.)
To: CONSYNANCE THERAPEUTICS, INC.
Reel/Frame 065771/0519 →
Security Interest Mar 7, 2025
From: CURIA GLOBAL, INC.; CURIA IP HOLDINGS, LLC; CURIA BIO, INC.
To: APOLLO ADMINISTRATIVE AGENCY LLC
Reel/Frame 070442/0908 →
Assignment of Security Interest in Intellectual Property, Recorded on September 1, 2017, at Reel/Frame 043746/0621 Mar 17, 2025
From: BARCLAYS BANK PLC, AS EXISTING AGENT
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT
Reel/Frame 070531/0279 →
Change of Name May 20, 2025
From: ALBANY MOLECULAR RESEARCH, INC.
To: CURIA GLOBAL, INC.
Reel/Frame 071298/0097 →
Partial Release of First Lien Intellectual Property Security Agreement Supplement Jun 3, 2025
From: APOLLO ADMINISTRATIVE AGENCY LLC
To: CURIA GLOBAL, INC.
Reel/Frame 071490/0880 →